Recent Comments

Comment RSS

Angiotensin News and Research RSS Feed - Angiotensin News and Research

Angiotensin is an oligopeptide in the blood that causes vasoconstriction, increased blood pressure, and release of aldosterone from the adrenal cortex. It is a powerful dipsogen. It is derived from the precursor molecule angiotensinogen, a serum globulin produced in the liver. It plays an important role in the renin-angiotensin system.

Carvedilol in combination with ACE inhibitors may benefit cardiac patients

21. November 2009 01:09
In a new study, researchers report that a class of heart medications called beta-blockers can have a helpful, or harmful, effect on the heart, depending on their molecular activity. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , ,

NHLBI-supported research shares new strategies on hypertension, heart defect and air pollution

20. November 2009 05:00
New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18. [More]

Publicly released report cards do not appear to improve hospitals' performance, says new study

19. November 2009 02:09
An analysis of quality of cardiac care following the public release of data on measures of care at hospitals in Ontario, Canada, did not result in significant systemwide improvement in hospitals' performance on most quality of care indicators, according to a study to be published in the December 2 issue of JAMA. The study is being released early online because of its presentation at an American Heart Association scientific conference. [More]

Posted in: Healthcare News

Tags: , , , ,

Study: Larger dose of ARBs is more effective in heart failure patients

18. November 2009 07:04
A larger dose of angiotensin receptor blockers (ARBs) is more effective than a smaller dose in heart failure patients, researchers said at the American Heart Association's Scientific Sessions 2009. [More]

Posted in: Medical Condition News | Pharmaceutical News

Tags: , ,

Drug therapy offers substantial cost savings than angioplasty

18. November 2009 00:43
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD. [More]

Aterovax presents results of its sPLA2 activity test in the PEACE trial

17. November 2009 04:29
Aterovax SA, a company developing innovative products for atherosclerosis, today announced data demonstrating that its blood test for secretory phospholipase A2 (sPLA2) activity significantly improves cardiovascular risk prediction in patients with stable coronary artery disease (CAD) over a 5 year period, independent of established risk markers, including C-reactive protein. [More]

Mayo Clinic Health Letter provides treatment options for people with heart disorders

16. November 2009 08:15
Fewer than one-third of patients with heart failure are taking the three types of medications that are most effective in prolonging life and improving quality of life. The November issue of Mayo Clinic Health Letter provides an overview of treatments recommended by national guidelines. [More]

Self-care tips for hemorrhoids from Mayo Clinic

16. November 2009 07:28
By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem. [More]

New Cat B 750 FAST imaging agent launched by VisEn Medical

12. November 2009 09:11
VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis. [More]

Posted in: Medical Science News

Tags: , , , , , , , , ,

Mesenchymal stem cells may be the key to healing diabetic foot ulcers

10. November 2009 05:09
Diabetic foot ulcers are the primary cause of hospital admissions for diabetics. Foot ulcers that heal improperly are at risk for infection, which can lead to amputation. According to the American Diabetes Association, one in four patients with diabetic foot ulcers will eventually require lower-limb amputation. Now science has found a way of mobilizing stem cells within the body to treat this health issue, which affects more than three million Americans annually. [More]

Posted in: Medical Science News | Medical Condition News

Tags: , , , , , , ,

Endothelin increases T cells in the kidneys leading to renal injury

6. November 2009 04:28
A key player in a cascade that likely begins with stress and leads to high blood pressure and kidney damage has been identified by researchers who say the finding may lead to better ways to control both. [More]

Report on immunotherapies and vaccines for nontraditional indications

27. October 2009 07:23
Reportlinker Adds Immunotherapies and Vaccines for Nontraditional Indications [More]

Preachers Coffee signs agreement to enhance its nutraceutical-health marketing strategy

23. October 2009 05:37
PREACHERS COFFEE, INC. (PINKSHEETS: PRCF) in order to enhance its Nutraceutical Health Marketing Strategy entered into an Agreement with "GANO EXCEL COFFEE COMPANY" -- a robust Multi Level Marketing Health Coffee Company that has a broad range of 3,000,000 customers with respect to population and followings. [More]

Posted in: Miscellaneous News

Tags: , , , , , , , , ,

Canadian Cardiovascular Society to honor University of Alberta medical researcher

23. October 2009 01:19
A University of Alberta medical researcher being hailed as a world leader in his field will receive a major national award for his pioneering work in the development of a new class of drugs for the treatment of heart failure. [More]

Two high blood pressure medicines effective in treating stable ischemic heart disease

20. October 2009 05:44
Two medications commonly used to treat high blood pressure appear to be effective in treating a common type of heart disease known as stable ischemic heart disease, according to a new comparative effectiveness review funded by HHS' Agency for Healthcare Research and Quality. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.